Clinical tests

Baby-Comp a sophisticated device used to fight unexplained infertility.

Clinical tests 

The computers have been clinically tested several times by Prof. Dr. G. Freundl, former Head Physician of the Department of Obstetrics and Gynecology at the Municipal Hospital of Düsseldorf-Benrath. The results have been presented at various medical conferences in Europe.

Clinical test "Effectiveness study" 

686 women from Germany, Switzerland and Mexico participated in the most recent study for over two years. The study was conducted at the University Hospital in Düsseldorf and resulted in a Pearl Index of 0.7. Please contact us to receive a summary of the study.

Clinical Evaluation “LadyComp / Pearly / BabyComp"

Clinical Expert, Dr. med. Andreas Marx, 2007

Valley Electronics GmbH develops and manufactures hand-held electronic fertility indicators for pregnancy prevention and family planning since years. The devices were designed in close cooperation with engineers, technicians, and gynecologists.
The devices under evaluation “Lady-Comp” and “Baby-Comp“ are commercially available since many years. The latest model “Pearly“ is a less featured and therefore a low-priced version within the product family of electronic fertility computers. However its technology is based on the reliable platform of the established models “Lady-Comp” and “Baby-Comp“.

The high measurement accuracy of the temperature sensors and the precise algorithm of the temperature calculation provide a high degree in method safety, which clearly stands out from competitive devices.

The handling and operation of the device is user friendly and easy; all relevant items which ensure a safe and correct application of the device are described comprehensibly in the instructions for use.

Several scientific investigations, which were published in recognized journals, provide substantial evidence of the contraceptive effectiveness and safety of the VE electronic fertility devices. All investigations and studies were conducted independently; non of the participating physicians received any financial grant nor had a relationship with the manufacturer Valley Electronics, thus allowing to consider the published data as reliable and objective.

The use of the fertility computers from Valley Electronics allows women to apply a contraceptive method which is based on the natural family planning method. The benefit of the devices obviously lies in a safe and adverse event-free method of contraception and family planning.

Clinical test "Planning" 

Under "Downloads" you will find a summary of the study conducted by Prof. S. Dessole and presented during the "International Meeting on Infertility and Assisted Reproductive Technology" in Porto Cervo in 1997.


Clinical tests

File: Tests/English/Baby_Comp/reliability.pdf
Last modifyed: 10. 01. 2010     Filesize: 83.69 kB
File: Tests/English/Downloads/DEKRA.pdf
Last modifyed: 10. 01. 2010     Filesize: 644.05 kB
File: Tests/English/Downloads/DEKRA_Annex.pdf
Last modifyed: 10. 01. 2010     Filesize: 329.10 kB
File: Tests/English/Downloads/DEKRA_EN ISO.pdf
Last modifyed: 10. 01. 2010     Filesize: 590.25 kB
File: Tests/English/Lady_Comp_pearly/Clinical_Tests.pdf
Last modifyed: 10. 01. 2010     Filesize: 69.73 kB
File: Tests/English/Downloads/Study_Reliability.pdf
Last modifyed: 10. 01. 2010     Filesize: 311.86 kB

The technical reliability of Baby-Comp

The study was conducted by the University of Sassari, Italy, whereby two methods for the prediction and detection of ovulation and for the diagnosis of luteal deficiency were compared and analyzed.
Compared where:

1. Common Clinical Methods: ultrasound, urinary Luteal Hormone (LG) testing's and by testing the progesterone level in the blood.
2. The BBT measurement method with Baby-Comp an electronic sophisticated fertility computer.

The study was performed on women who were detected as being infertile for the last three to eight years.
Both methods yielded almost equal results. A small aberration was found: in two out of thirty analyzed cycles, Baby-Comp did not exactly predict ovulation.
All other points evaluated prevailed 100% consensus. 

Study of Prof. Salvatore Dessole, Universtiy Sassari